Disclosure of Payments to Healthcare Professionals

Across Europe, by 30 June 2018, the pharmaceutical industry will disclose payments made to health professionals, such as sponsorship to attend meetings, speaker fees, consultancy and advisory boards. Bringing greater transparency to this, already well-regulated, vital relationship is about strengthening the basis for collaboration in the future. Industry is being proactive, based on its commitment to this relationship. Collaboration between industry and health professionals benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives. Industry and health professionals collaborate in a range of activities from clinical research to sharing best clinical practice and exchanging information on how new medicines fit into the patient pathway. Society has increasingly high expectations for transparency, none more so than in healthcare. As a member of EFPIA, Pierre Fabre group want to ensure we meet those expectations complying with EFPIA Disclosure Code.

Self certification letter

About the EFPIA Disclosure Code

The EFPIA Disclosure Code is a code of conduct that requires all EFPIA member companies and companies that are members of EFPIA member associations to disclose transfers of value to Healthcare Professionals (HCPs) and healthcare organizations (HCOs).

The first disclosures were made by 30 June 2016, for payments made in 2015. For Pierre Fabre affiliates in Europe, Russia, this information will be published on a public platform, which could be on a central national platform, combing data from different companies, on each affiliate company’s own website or, on the company’s corporate website when affiliate doesn’t have its own website (see after for these public disclosures).

Disclosure Methodology Pierre Fabre Pharmaceuticals 2017

Disclosure Methodology Pierre Fabre Pharmaceuticals 2016

Austria


Belgium

Bulgaria


Czech Republic


    Denmark

    Estonia


    Finland


    France


    Germany


    Greece


    Hungary


    Italy


    Ireland

    Lithuania


    Poland


    Portugal

    Romania

    Russia

    Slovak republic


    Spain

    Sweden

    Switzerland


    Ukraine

    United Kingdom





    Following European legislation on data privacy, recipients of published transfers of value have a right to access and correct personal data concerning them, which is exercisable by email.

    For further information about the EFPIA disclosure code